Recent changes
Jump to navigation
Jump to search
Track the most recent changes to the wiki on this page.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
2 June 2024
03:28 | WINREVAIR diffhist +581 Kosar Doraghi talk contribs |
|
02:54 | (Upload log) [Kosar Doraghi (9×)] | |||
|
02:54 Kosar Doraghi talk contribs uploaded File:IMG 1235.jpeg | ||||
|
02:53 Kosar Doraghi talk contribs uploaded File:IMG 1234.jpeg | ||||
|
02:52 Kosar Doraghi talk contribs uploaded File:IMG 1231.jpeg | ||||
|
02:51 Kosar Doraghi talk contribs uploaded File:IMG 1232.jpeg | ||||
|
02:49 Kosar Doraghi talk contribs uploaded File:IMG 1230.jpeg | ||||
|
02:49 Kosar Doraghi talk contribs uploaded File:IMG 1227.jpeg | ||||
|
02:48 Kosar Doraghi talk contribs uploaded File:IMG 1236.jpeg | ||||
|
02:46 Kosar Doraghi talk contribs uploaded File:IMG 1237.jpeg | ||||
|
02:41 Kosar Doraghi talk contribs uploaded File:IMG 1226.jpeg |
1 June 2024
03:21 | Template:KDRG diffhist +15 Kosar Doraghi talk contribs |
N 03:20 | WINREVAIR diffhist +16,566 Kosar Doraghi talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:k.doraghi@yahoo.com] |genericName=sotatercept-csrk |aOrAn=an |drugClass=activin signaling inhibitor |indicationType=treatment |indication=adults with pulmonary arterial hypertension (PAH, WHO Group 1) to increase exercise capacity, improve WHO functional class (FC) and reduce the risk of clinical worsening events |hasBlackBoxWarning=Yes |adverseReactions=headache, epistaxis, rash, telangiect...") |